Last reviewed · How we verify
NCT07439458: TCReX
Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity
NA trial testing High intensity continuous exercise in Acute Exercise in 40 participants. Currently enrolling.
31 March 2026
Quick facts
| Lead sponsor | Riga Stradins University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 1 April 2024 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Latvia |
Drugs / interventions tested
- High intensity continuous exercise
- Moderate intensity continuous exercise
Conditions studied
- Acute Exercise — all drugs for Acute Exercise →
- Breast Cancer Cell Lines — all drugs for Breast Cancer Cell Lines →
- Breast Cancer Survivors — all drugs for Breast Cancer Survivors →
- Healthy Women — all drugs for Healthy Women →
Sponsor
Riga Stradins University
Who can join
35 and older, female only, with Acute Exercise or Breast Cancer Cell Lines. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cancer has emerged as a prominent cause of mortality in the 21st century, with breast cancer (BC) being the most diagnosed malignancy. Multidisciplinary cancer management has improved survival chances, but side effects and long-term consequences of treatments have significant implications for cancer survivors' health-related quality of life. Exercise is increasingly considered and used in cancer treatment and follow-up. However, studies demonstrating the biological mechanisms underlying the anticarcinogenic effects (ACE) of exercise are insufficient to justify the most appropriate physical activity for different clinical scenarios. Achieving scientific excellence in understanding the ACE of exercise in cancer management is critical to optimize treatment and enhance patients' quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07439458
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High intensity continuous exercise
Trials testing the same drug.
- NCT05574413 — Impact of Acute Exercise Intensity and Pattern on Cytokine Function · NA · completed
Other recruiting trials for Acute Exercise
Currently open trials in the same condition.
- NCT06645119 — Protein Ingestion on BMM Response in Endurance Runners · NA · active not recruiting
Other Riga Stradins University trials
Trials by the same sponsor.
- NCT06551454 — Smart Textile Solutions as Biofeedback Method for Injury Prevention for Latvian Football Youth League Players · NA · recruiting
- NCT07511686 — Metabolic and Mitochondrial Changes in Statin-Induced Myopathy · completed
- NCT07304921 — Novel Approach to Increase EPA and DHA Levels · Phase 1 · completed
- NCT06734962 — Evaluation of Bone Regeneration After Apical Surgery Using Advanced Platelet-rich Fibrin: Utilization of Ultrasound for · Phase 2 · active not recruiting
- NCT06442085 — Virtual Reality Training for Trauma Resuscitation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07439458 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riga Stradins University
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07439458.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing